Company had a strong start to 2025, emerging as an R&D-focused organization Exclusive license agreement with Novo Nordisk for LX9851 executed; IND-enabling studies on track for completion in 2025 Phas ...

The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.

Most major stock indexes across the globe moved upwards on a weekly basis, taking support from the uptick in US equities.

U.S. stocks are set to wrap a winning week as tariff and trade fears ease, President Trump winds down his Middle East trip securing billions of investments for the U.S. and Warren Buffett’s Berkshire ...

Much has been learned about GLP-1s over many years, but little is understood about why the degree of response to them varies ...

Trump is “in peak physical and mental condition,” White House Press Secretary Karoline Leavitt told The Atlantic in an ...

Wall Street cruised to the finish of its strong week on Friday, as U.S. stocks glided closer to the all-time high they set ...

Wall Street cruised to the finish of its strong week on Friday, as U.S. stocks glided closer to the all-time high they set ...

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

To be clear, that concern was well-founded: High drug prices are one reason the U.S. has become a global leader in medical ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics ( VKTX 3.61%) stock on Friday, which closed the trading session 3% higher. That figure was well ...